Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 3,100.00
+150.00 (5.08%)
At close: Sep 4, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 186.51 billion as of September 4, 2026. Its market cap has decreased by -47.36% in one year.
Market Cap
186.51B
Enterprise Value
209.28B
Revenue
50.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,100.00
ChartMarket Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 186.51B, an increase of 157.43%. That is a compound annual growth rate of 4.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 186.51B | -7.06% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 279.71B |
| ImmuneOncia Therapeutics | 263.97B |
| DAE HWA Pharmaceutical | 201.91B |
| GC WellBeing | 185.67B |
| NOVAREX | 180.11B |
| Cosmax Nbt | 176.36B |
| CellBion | 154.99B |
| Kyung Dong Pharmaceutical | 149.72B |